{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for vitamin root_references_url in Reference URL (approximate match)
Status:
Investigational
Source:
NCT00791570: Phase 1 Interventional Completed Neovascular Maculopathy
(2008)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:pemziviptadil [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT01897480: Phase 2 Interventional Active, not recruiting Carcinoma, Non-Small-Cell Lung
(2013)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT00146432: Phase 2/Phase 3 Interventional Completed Septicemia
Source URL:
Class:
PROTEIN
Class:
PROTEIN
Status:
Investigational
Source:
NCT00537420: Phase 2 Interventional Completed Obesity
(2007)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT02137343: Phase 3 Interventional Terminated Gastric Cancer
(2014)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03078400: Phase 1 Interventional Unknown status Ovarian Epithelial Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
FDA ORPHAN DRUG:878622
Source URL:
Class:
PROTEIN
Status:
Designated
Source:
FDA ORPHAN DRUG:723219
Source URL:
Class:
PROTEIN